Repeat Injection Studies of Technetium-99M-Labeled Peg-Liposomes in the Same Animal
The DOI matches its Crossref record.
Abstract
This study was designed to determine if repeat injections of polyethylene glycol (PEG) coated liposomes in the same animal lead to a change in biodistribution due to a biological response. To evaluate the long-term storage of PEG-liposomes for imaging applications and to remove any concerns of batch variability, one large batch of PEG-liposomes containing glutathione and sucrose was prepared and used for the entire study. On each day that an imaging study was performed, an aliquot of PEG-liposomes were labeled with techne-tium-99m (99mTc) using hexamethylpropyleneamine oxime. Rabbits (n = 4) were injected with 99mTc-PEG-liposomes (2 ml; 13 mg phospholipid/kg body wt; 2 mCi 99mTc-activity) at 8 days after manufacture and imaged under a gamma camera. Heart-to-lung ratios, heart-to-liver ratios and organ activities were determined by region of interest analysis. Blood samples were collected to generate blood clearance curves. Six weeks later the same rabbits were given a second dose of 99mTc-PEG-liposomes at 50 days after manufacture and imaged as before. A set of new rabbits (n = 3) were also imaged at six weeks using 99mTc-PEG-liposomes in order to differentiate any differences in organ distribution due to storage vs. reinjection. Images acquired for each set of rabbits at 30 minutes demonstrated little change in organ distribution following reinjection. Heart-to-lung ratios decreased from 2.25 ± 0.06 at baseline to 2.05 0.05 on reinjection and 2.10 ± 0.01 upon storage. Heart-to-liver ratios were 1.46 ± 0.06 on reinjection, significantly lower than the ratio of 1.72 ± 0.10 at baseline or 1.68 ± 0.09 upon storage. Circulation half-life of 29 hours did not change within the three groups. Although a slight change in organ biodistribution occurred with storage and reinjection, these effects were minimal and are not likely to affect drug targeting or diagnostic imaging on repeat injection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Samaridou, E., Heyes, J., & Lutwyche, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.002 · Cited by 583
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
PEGylated liposomes: immunological responses
Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 523
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 340
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00174 · Cited by 313
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
“Enhanced blood clearance of repeated doses of technetium-99m-PEG liposomes occurred when the second injection was administered between 5 days and 4 weeks after the initial injection (Goins et al., 1998; Oussoren and Storm, 1999; Dams et al., 2000).”
BackgroundInfluential
Metadata
- Authors
- Coins, B., Phillips, W. T., & Klipper, R.
- Venue
- Journal of Liposome Research
- Publisher
- Informa UK Limited
- Published
- 1998-01
- Volume
- 8
- Issue
- 2
- Pages
- 265-281
- ISSN
- 0898-2104 (ISSN-L)
- 1532-2394
- OpenAlex
- W2066622033
- Cited by
- 31
- References
- 0
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.